428
Views
7
CrossRef citations to date
0
Altmetric
Reviews

What is the risk of hyperkalaemia in heart failure?

, , &
Pages 2329-2338 | Published online: 19 Jul 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Raquel López-Vilella, Herminio Morillas-Climent, Diego Plaza-López, Mónica Cebrián-Pinar, Ignacio Sánchez-Lázaro & Luis Almenar-Bonet. (2016) Hyperkalemia in heart failure patients: current challenges and future prospects. Research Reports in Clinical Cardiology 7, pages 1-8.
Read now

Articles from other publishers (6)

Tahani Nasser Alrashidi, Razan Ahmed Alregaibah, Khalaf Abdullah Alshamrani, Ahmed A Alhammad, Razan H Alyami, Mawadda Abdullah Almadhi, Mohamed E Ahmed & Hind Almodaimegh. (2020) Hyperkalemia Among Hospitalized Patients and Association Between Duration of Hyperkalemia and Outcomes. Cureus.
Crossref
Anan Younis, Ilan Goldenberg, Ronen Goldkorn, Arwa Younis, Yael Peled, Boaz Tzur & Robert Klempfner. (2017) Elevated Admission Potassium Levels and 1-Year and 10-Year Mortality Among Patients With Heart Failure. The American Journal of the Medical Sciences 354:3, pages 268-277.
Crossref
Maria Lukács Krogager, Lotti Eggers-Kaas, Kristian Aasbjerg, Rikke Nørmark Mortensen, Lars Køber, Gunnar Gislason, Christian Torp-Pedersen & Peter Søgaard. (2015) Short-term mortality risk of serum potassium levels in acute heart failure following myocardial infarction. European Heart Journal - Cardiovascular Pharmacotherapy 1:4, pages 245-251.
Crossref
Sascha Abbas, Peter Ihle, Sebastian Harder & Ingrid Schubert. (2015) Risk of hyperkalemia and combined use of spironolactone and long-term ACE inhibitor/angiotensin receptor blocker therapy in heart failure using real-life data: a population- and insurance-based cohort. Pharmacoepidemiology and Drug Safety 24:4, pages 406-413.
Crossref
Kannayiram Alagiakrishnan, Maciej Banach, Linda G. Jones, Ali Ahmed & Wilbert S. Aronow. (2013) Medication Management of Chronic Heart Failure in Older Adults. Drugs & Aging 30:10, pages 765-782.
Crossref
Miriam T. RademakerChristopher J. CharlesM. Gary NichollsA. Mark Richards. (2013) Interactions of Enhanced Urocortin 2 and Mineralocorticoid Receptor Antagonism in Experimental Heart Failure. Circulation: Heart Failure 6:4, pages 825-832.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.